Literature DB >> 20111614

Role of prophylactic central neck dissection in cN0 papillary thyroid cancer.

S Costa1, G Giugliano, L Santoro, A Ywata De Carvalho, M A Massaro, B Gibelli, E De Fiori, E Grosso, M Ansarin, L Calabrese.   

Abstract

Prophylactic central neck dissection in papillary thyroid cancer is controversial. In this retrospective cohort study, the aim was to assess possible advantages of prophylactic central neck dissection with total thyroidectomy in cN0 papillary thyroid cancer. A total of 244 consecutive patients with papillary thyroid cancer, without clinical and ultrasound nodal metastases (cN0), were evaluated out of 1373 patients operated for a thyroid disease at the Istituto Europeo di Oncologia, Milan, Italy from 1994 to 2006. Of these 244 patients, 126 (Group A) underwent thyroidectomy with central neck dissection, while 118 (Group B) underwent thyroidectomy alone. Demographic, clinical and pathological features were analysed. Overall recurrence rate was 6.3% (8/126) in Group A and 7.7% (9/118) in Group B, with a mean follow-up of 47 (Group A) and 64 (Group B) months. In Group A patients, 47% were pN1a and all patients with recurrence had nodal involvement (p = 0.002). Survival rate did not differ in the two groups. Nine patients were lost to follow-up. Group A patients were older and their tumours were larger in size; according to the pT distribution, a higher extra-capsular invasion rate was observed. The two groups were equivalent as far as concerns histological high risk variants and multifocality. Nodal metastases correlated with stage: pT1-2 vs. pT3-T4a, p = 0.0036. A lower risk of nodal metastases was related to thyroiditis (p = 0.0034). In conclusion, central neck metastases were predictive of recurrence without influencing prognosis. From data obtained, possible greatest efficacy of central neck dissection in pT3-4 papillary thyroid cancer without thyroiditis is suggested.

Entities:  

Keywords:  Central neck dissection; Nodal metastases; Papillary thyroid cancer; Thyroid

Mesh:

Year:  2009        PMID: 20111614      PMCID: PMC2808683     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  25 in total

1.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Steven I Sherman; R Michael Tuttle
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

2.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

3.  Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid.

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

4.  Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma.

Authors:  José A Pereira; Jaime Jimeno; Joana Miquel; Mar Iglesias; Asumpta Munné; Joan J Sancho; Antonio Sitges-Serra
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

5.  The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.

Authors:  Maisie Shindo; James C Wu; Eunice E Park; Frances Tanzella
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2006-06

6.  Improved survival of patients with papillary thyroid cancer after surgical microdissection.

Authors:  L E Tisell; B Nilsson; J Mölne; G Hansson; M Fjälling; S Jansson; U Wingren
Journal:  World J Surg       Date:  1996-09       Impact factor: 3.352

7.  Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis.

Authors:  C J Hughes; A R Shaha; J P Shah; T R Loree
Journal:  Head Neck       Date:  1996 Mar-Apr       Impact factor: 3.147

8.  Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland?

Authors:  N Sato; M Oyamatsu; Y Koyama; I Emura; Y Tamiya; K Hatakeyama
Journal:  J Surg Oncol       Date:  1998-11       Impact factor: 3.454

9.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].

Authors:  S A Hundahl; I D Fleming; A M Fremgen; H R Menck
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

10.  Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer.

Authors:  G F Scheumann; O Gimm; G Wegener; H Hundeshagen; H Dralle
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

View more
  15 in total

1.  Clinical value of elasticity imaging and contrast-enhanced ultrasound in the diagnosis of papillary thyroid microcarcinoma.

Authors:  Fengsheng Li; Jianlei Zhang; Yunmei Wang; Liwen Liu
Journal:  Oncol Lett       Date:  2015-06-17       Impact factor: 2.967

Review 2.  Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Juan J Sancho; Thomas W Jay Lennard; Ivan Paunovic; Frédéric Triponez; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2013-12-19       Impact factor: 3.445

Review 3.  Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Authors:  Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Carlos Suárez; Phillip K Pellitteri; Ashok R Shaha; Marc Hamoir; K Thomas Robbins; Avi Khafif; Juan P Rodrigo; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito; Dana M Hartl
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-11       Impact factor: 2.503

4.  MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.

Authors:  Adriana Sondermann; Flavia Maziero Andreghetto; Ana Carolina Bernardini Moulatlet; Elivane da Silva Victor; Marilia Germanos de Castro; Fábio Daumas Nunes; Lenine Garcia Brandão; Patricia Severino
Journal:  Clin Exp Metastasis       Date:  2015-05-26       Impact factor: 5.150

5.  Propensity score-matched analysis of robotic versus endoscopic bilateral axillo-breast approach (BABA) thyroidectomy in papillary thyroid carcinoma.

Authors:  Seo Ki Kim; Jung-Woo Woo; Inhye Park; Jun Ho Lee; Jun-Ho Choe; Jung-Han Kim; Jee Soo Kim
Journal:  Langenbecks Arch Surg       Date:  2016-10-24       Impact factor: 3.445

Review 6.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

7.  BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence.

Authors:  Jason D Prescott; Peter M Sadow; Richard A Hodin; Long Phi Le; Randall D Gaz; Gregory W Randolph; Antonia E Stephen; Sareh Parangi; Gilbert H Daniels; Carrie C Lubitz
Journal:  Surgery       Date:  2012-12       Impact factor: 3.982

Review 8.  The pros and cons of routine central compartment neck dissection for clinically nodal negative (cN0) papillary thyroid cancer.

Authors:  Ai Chen Chan; Brian Hung Hin Lang; Kai Pun Wong
Journal:  Gland Surg       Date:  2013-11

Review 9.  Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma with Clinically Uninvolved Central Neck Lymph Nodes: A Systematic Review and Meta-analysis.

Authors:  Lawrence Chen; Yi-Hsiu Wu; Chia-Hwa Lee; Hsin-An Chen; El-Wui Loh; Ka-Wai Tam
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

10.  Central neck dissection in differentiated thyroid cancer: technical notes.

Authors:  G Giugliano; M Proh; B Gibelli; E Grosso; M Tagliabue; E De Fiori; F Maffini; F Chiesa; M Ansarin
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-02       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.